Virus News and Research

Latest Virus News and Research

World Tuberculosis Day 2022: an interview with Dr. Maxine Caws

For World Tuberculosis Day 2022, News Medical spoke to Dr. Maxine Caws to raise awareness of this infectious disease.

24 Mar 2022

SARS-CoV-2 is evolving adaptively in multiple regions of the genome

Scientists from the United States have recently assessed the evolutionary success of mutations accumulated across severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome. They have observed that the positively-selected mutations in the viral spike S1 subunit are primarily responsible for adaptive evolution. This indicates that the virus may undergo antigenic drift.

23 Mar 2022

Researchers investigate Galectin-9 as a new treatment target for COVID-19

Researchers discuss alternate therapeutic targets for treating COVID-19 and the effects of Gal-9 on SARS-CoV-2 infection and the immune response.

23 Mar 2022

Researcher wins three NIH grants to tackle mosquito-borne viruses

West Nile virus, Usutu virus, Zika virus, and St. Louis encephalitis virus are all transmitted by mosquitoes and cause a significant threat to human health.

23 Mar 2022

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

There is likely recombination of genome sequences between the SARS-CoV-2 Delta and Omicron variants in their spike (S) protein.

23 Mar 2022

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in animals on track with vaccines currently in clinical use.

23 Mar 2022

INTEGRA’s ASSIST PLUS pipetting robot helps to streamline sample pooling for arbovirus testing

INTEGRA Biosciences’ ASSIST PLUS pipetting robot is helping the Arbovirus Testing Lab at the New Hampshire Public Health Laboratories in Concord, USA, to streamline sample pooling for West Nile and Eastern equine encephalitis virus testing.

From INTEGRA Biosciences 23 Mar 2022

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

New York Blood Center’s Project ACHIEVE and Columbia University’s Columbia Research Unit are working in partnership for the New York City effort to advance the use of messenger ribonucleic acid (mRNA) technology in an HIV preventive vaccine study – HVTN 302.

23 Mar 2022

Study shows link between psychotropic medication use and post-Covid dementia

Recent studies have highlighted the connection between coronavirus disease 2019 (COVID-19) infection and the development of dementia.

23 Mar 2022

Seafood workers twice as likely to contract COVID-19 as workers in other food industries

The dramatic toll that COVID-19 has taken on the U.S. is apparent, but as caseloads come down and mandates are loosened it has become increasingly obvious how much of an impact the pandemic had on food service workers in industries like the fisheries.

23 Mar 2022

Importance of Numb-associated kinases in SARS-CoV-2 infection

A new study posted to the bioRxiv* preprint server has focussed on assessing four members of the NAK family that are associated with SARS-CoV-2 infection. These kininases could act as a target for the development of effective COVID-19 therapeutics.

23 Mar 2022

Scientists identify a promising strategy for stopping Ebola virus polymerase

To treat Ebola virus infections, researchers are taking a close look at a key piece of the virus: polymerase.

23 Mar 2022

Detection of immune and clotting dysfunction in plasma and saliva after SARS-CoV-2 infection

It is becoming increasingly clear that individuals recovering from acute coronavirus disease (COVID-19) may develop post-acute sequelae (Post-Acute Coronavirus Syndrome, PACS).

23 Mar 2022

Breakthrough hospitalizations for COVID-19, less likely to happen in vaccinated or previously infected people

Fewer than 1 in 1,000 people who have been vaccinated or previously infected with COVID-19 were hospitalized with a new breakthrough infection, Mayo Clinic research finds.

22 Mar 2022

New model suggests long-range transmission of SARS-CoV-2

A new study describes the long-range transmission of SARS-CoV-2 through aerosolized particles as a possibility.

22 Mar 2022

Monitoring SARS-CoV-2 Ct values during early infection

A new study tracks the fluctuations in viral load in people recently infected with SARS-CoV-2.

22 Mar 2022

Oral version of remdesivir could extend its reach and benefits to COVID-19 patients

Scientists at the University of North Carolina at Chapel Hill are testing a new route for remdesivir, a pill form of the COVID-19 treatment that’s given to half of all hospitalized patients with the disease.

22 Mar 2022

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

Researchers evaluate antiviral effects of CD63 tetraspanin extracellular vesicles against SARS-CoV-2 and HIV-1.

22 Mar 2022

Rubella antibodies vs. COVID-19

A new study describes a potential relationship between antibody titers against the rubella virus and the severity of COVID-19.

22 Mar 2022

The relative performance of OPS, NPS, and saliva for detecting the Delta and Omicron SARS-CoV-2 variants

Scientists have worked extensively hard to contain the COVID-19 pandemic caused by the rapid transmission of SARS-CoV-2.

22 Mar 2022

Virus News and Research

Latest Virus News and Research

World Tuberculosis Day 2022: an interview with Dr. Maxine Caws

SARS-CoV-2 is evolving adaptively in multiple regions of the genome

Researchers investigate Galectin-9 as a new treatment target for COVID-19

Researcher wins three NIH grants to tackle mosquito-borne viruses

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

INTEGRA’s ASSIST PLUS pipetting robot helps to streamline sample pooling for arbovirus testing

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

Study shows link between psychotropic medication use and post-Covid dementia

Seafood workers twice as likely to contract COVID-19 as workers in other food industries

Importance of Numb-associated kinases in SARS-CoV-2 infection

Scientists identify a promising strategy for stopping Ebola virus polymerase

Detection of immune and clotting dysfunction in plasma and saliva after SARS-CoV-2 infection

Breakthrough hospitalizations for COVID-19, less likely to happen in vaccinated or previously infected people

New model suggests long-range transmission of SARS-CoV-2

Monitoring SARS-CoV-2 Ct values during early infection

Oral version of remdesivir could extend its reach and benefits to COVID-19 patients

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

Rubella antibodies vs. COVID-19

The relative performance of OPS, NPS, and saliva for detecting the Delta and Omicron SARS-CoV-2 variants

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in